North America Clinical Chemistry Analyzers and Reagent Market

2023-2027 North America Clinical Chemistry Analyzers and Reagent Market--Supplier Shares, Volume and Sales Segment Forecasts for 55 Tests in the US, Canada, Mexico--Emerging Opportunities, Growth Strategies, Latest Technologies and Instrumentation Pipeline

This new 3-country report from is available by country, market segment, section, or individual test.

The report is available by section, and can be customized to specific information needs and budget.

This report provides a granular strategic analysis of over 55 clinical chemistry assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.

To fit your research budget and receive sections of this report or specific data on geographic regions, countries, markets, companies, technologies and products, select the exact information you need from our In Vitro Diagnostics Database.

Rationale

The clinical chemistry market is undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Country Analyses

Canada, Mexico, USA

Market Segmentation Analysis

- Comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.

- Test volume and sales forecasts for over 55 clinical chemistry assays.

Individual Tests Analyzed in the Report

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, Apolipoprotein A-1, Apolipoprotein B, AST/SGOT, Beta-Hydroxybutyrate, Bilirubin (Direct), Bilirubin (Total), BNP, BUN (Blood Urea Nitrogen), Calcitonin, Calcium, Carbon Dioxide/Bicarbonate, Cardio hs CRP, Chloride, Cholesterol, Cholinesterase, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Cystatin C, Ferritin, Fructosamine, GGT, Glucose, HDL Cholesterol, Homocysteine, hs-CRP, Insulin, Iron, Iron (Total Binding Capacity), Iron (Unsaturated Binding Capacity), LDH, LDL Cholesterol, LDL Cholesterol Direct, Lipase, Lipoprotein a, Magnesium, Microalbumin, Myoglobin, NT-proBNP, Phosphorus, Potassium, Sodium, ST2, Total Protein, Transferrin, Triglycerides, Troponin, Uric Acid

Current and Emerging Products

- Analysis of current and emerging clinical chemistry tests.

- Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Review

- Assessment of current and emerging technologies, and their potential market applications.

- Companies developing or marketing new technologies and products by test.

Strategic Recommendations

- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.

Competitive Assessments

- Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new products in R&D. The companies analyzed in this report include:

- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter/Danaher
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Fujifilm Wako
- Fujirebio
- Grifols
- Instrumentation Laboratory/Werfen
- Kyowa Medex
- PerkinElmer
- Quest Diagnostics
- QuidelOrtho
- Roche
- Siemens Healthineers
- Sysmex
- Thermo Fisher
- Tosoh

I. Introduction
II. Major Product Development Opportunities
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
A. InternalDevelopment
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Worldwide Market and Technology Overview
A. Selected Tests Clinical Significance and Diagnostic Procedures
1. Albumin
2. Alkaline Phosphatase
3. ALT/SGPT
4. Ammonia
5. Amylase
6. AST/SGOT
7. Bilirubin, Total
8. Blood Gases
9. Blood Urea Nitrogen (BUN)
10. BNP
11. Calcium
12. Cardio CRP
13. Cholesterol
14. Cholinesterase

15. CRP
16. Creatinine
17. Electrolytes
a. Carbon Dioxide/Bicarbonate
b. Chloride
c. Potassium
d. Sodium
18. Ferritin
19. Fructosamine
20. Gamma-Glutamyl Transpeptidase (GGT)
21. Glucose
22. High Density Lipoprotein (HDL)
23. Homocysteine
24. hs-CRP
25. Iron
26. Lactate Dehydrogenase (LDH)
27. Magnesium
28. NT-proBNP
29. Phosphorus
30. Protein
31. ST2
32. Triglycerides
33. Uric Acid
34. Troponin
B. Clinical Chemistry Instrumentation Review: Operating
Characteristics and Features of High-, Medium-, and
Low-volume/POC analyzers
C. Major Clinical Chemistry Technologies
And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors

VII. Country Analyses
Canada, Mexico, USA
VIII. Competitive Assessments
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako

List Of Tables

Canada Total Chemistry and Immunoassay
Specimen Volume Forecast by Specimen Type
Canada All Market Segments, Routine
Chemistry Test Volume Forecast by Assay
Canada Clinical Chemistry and Immunoassay
Calibrator and Control Market Forecast
by Test Category
Canada All Market Segments, Routine
Chemistry Reagent Market Forecast by Assay
Canada Clinical Chemistry and Immunoassay
Instrument Market Forecast by Analyzer Type
Mexico Total Chemistry and Immunoassay
Specimen Volume Forecast by Specimen Type
Mexico All Market Segments, Routine
Chemistry Test Volume Forecast by Assay
Mexico Clinical Chemistry and Immunoassay
Calibrator and Control Market Forecast
by Test Category
Mexico All Market Segments, Routine
Chemistry Reagent Market Forecast by Assay
Mexico Clinical Chemistry and Immunoassay
Instrument Market Forecast by Analyzer Type
U.S.A. Executive Summary Table: Clinical Chemistry
and Immunoassay Test Volume and Diagnostics Sales
Forecast by Test Category
U.S.A., Laboratories Performing Chemistry and
Immunoassay Testing by Market Segment
U.S.A., Hospital Laboratories Performing Chemistry
and Immunoassay Tests by Bed Size
U.S.A., Commercial/Private Laboratories Performing
Chemistry and Immunoassay Tests by
Annual Test Volume

U.S.A., Total Chemistry and Immunoassay
Specimen Volume Forecast
U.S.A., All Market Segments, Specimen Volume
Forecast by Test Category
U.S.A., Total Clinical Chemistry and Immunoassay
Test Volume Forecast by Test Category
U.S.A., Routine Chemistry Test Volume
Forecast by Market Segment
U.S.A., All Market Segments, Profiles,
Panels and Individual Tests Forecast
U.S.A., Hospital Laboratories, Profiles,
Panels and Individual Tests Forecast
U.S.A., Commercial/Private Laboratories,
Profiles, Panels and Individual Tests Forecast
U.S.A., Physician Offices/Group Practices,
Profiles, Panels and Individual Tests Forecast
U.S.A., All Market Segments, Routine Chemistry
Test Volume Forecast by Assay
U.S.A., Hospital Laboratories, Routine Chemistry
Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Routine Chemistry Test Volume
Forecast by Assay
U.S.A., Physician Offices/Group Practices,
Routine Chemistry Test Volume
Forecast by Assay
U.S.A., Total Clinical Chemistry and Immunoassay
Reagent Market Forecast by Test Category
U.S.A., Clinical Chemistry and Immunoassay Calibrator
and Control Market Forecast by Test Category

U.S.A., Routine Chemistry Reagent Market
Forecast by Market Segment
U.S.A., All Market Segments, Routine Chemistry
Reagent Market Forecast by Assay
U.S.A., Hospital Laboratories, Routine Chemistry
Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories,
Routine Chemistry Reagent Market
Forecast by Assay
U.S.A., Physician Offices/Group Practices,
Routine Chemistry Reagent Market
Forecast by Assay
U.S.A., Major Suppliers of Clinical Chemistry Reagents,
Estimated Sales and Market Shares
U.S.A., Major Suppliers of Clinical Chemistry Analyzers,
Estimated Instrument Sales and Market Shares
U.S.A., Major Suppliers of Clinical Chemistry
Diagnostics Products, Estimated Sales
and Market Shares
U.S.A., Major Suppliers of Immunoassay Reagents,
Estimated Sales and Market Shares
U.S.A., Major Suppliers of Immunoassay Analyzers,
Estimated Instrument Sales and Market Shares
U.S.A., Major Suppliers of Immunoassay
Diagnostics Products, Estimated Sales and
Market Shares
U.S.A., Clinical Chemistry and Immunoassay
Instrument Market Forecast by Analyzer Type

North America Nucleic Acid Testing Market Opportunities in the US, Canada, Mexico

North America Nucleic Acid Testing Market Opportunities in the US, Canada, MexicoThis new 3-country report is available by country, market segment, section, or individual test. The report is designed to

USD 9700 View Report

North America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market—Growth Opportunities in the US, Canada, Mexico

North America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics MarketGrowth Opportunities in the US, Canada, MexicoThe report is available by section, market segment, and can be customized to your

USD 6500 View Report

North America Nucleic Acid Testing Market Opportunities in the US, Canada, Mexico

North America Nucleic Acid Testing Market Opportunities in the US, Canada, MexicoThis new 3-country report is available by country, market segment, section, or individual test. The report is designed to

USD 9700 View Report

North America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market—Growth Opportunities in the US, Canada, Mexico

North America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics MarketGrowth Opportunities in the US, Canada, MexicoThe report is available by section, market segment, and can be customized to your

USD 6500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available